Business · 16/12/2025
FDA Announces Final Guidance on Investigator Responsibilities for Safety Reporting of Investigational Drugs and Devices
The FDA has released a final guidance document to help clinical investigators comply with safety reporting requirements for IND and IDE studies, providing recommendations on identifying necessary safety information to be reported to sponsors and IRBs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →